Johnson & Johnson (JNJ) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
11 Mar, 2026Voting matters and shareholder proposals
Election of 12 directors, with each nominee recommended for election by the board.
Advisory vote to approve named executive officer compensation is on the agenda.
Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm is proposed.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
The meeting will be held virtually, allowing shareholders to attend, vote, and submit questions online.
Executive compensation and say-on-pay
Advisory vote on executive compensation is included as a key agenda item.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Johnson & Johnson
- Shareholders to vote on board, Say on Pay, auditor, and board chair proposal amid strong results.JNJ
Proxy Filing11 Mar 2026 - Integrated robotic platform and digital ecosystem set to redefine surgical innovation and efficiency.JNJ
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Innovation and portfolio shifts set the stage for double-digit growth and margin expansion.JNJ
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Strong growth, increased dividends, and all management proposals approved; shareholder proposals failed.JNJ
AGM 20253 Feb 2026 - Focused healthcare strategy and innovation pipeline drive global growth and efficiency.JNJ
Goldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026 - Q2 sales up 4.3% to $22.4B, adjusted EPS up 10.2%, and 2024 guidance raised after key acquisitions.JNJ
Q2 20243 Feb 2026 - 2025 saw strong growth and innovation, with 2026 guidance projecting further acceleration.JNJ
Q4 202527 Jan 2026 - Confident in 2025+ growth, driven by innovation, M&A, and transformative pipeline assets.JNJ
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Cardiovascular and robotics drive growth as vision and orthopedics rebound amid China headwinds.JNJ
2024 Wells Fargo Healthcare Conference22 Jan 2026